Research on Bifidobacteria and prebiotic xylooligosaccharides (XOS) is essential for advancing gut health solutions. Bifidobacteria support immunity and digestion, but their levels can decline due to aging or diet changes. Unlike well-known prebiotics, XOS may selectively boost Bifidobacteria growth at lower doses, making it a promising dietary intervention. This work fills a gap in identifying natural compounds that support beneficial gut bacteria without promoting harmful ones, potentially enhancing gut health naturally and reducing reliance on medications.
- About the Office of Research
- Welcome Message
- Meet the Vice-President (Research)
- Strategic Research Plan
- Mission Statement
- Services and Divisions
- Discover our Research
- Research Chairs
- Facts and Figures
- Centres, Institutes, and Groups
- International Research
- Find a Researcher
- For Researchers
- Safeguarding Research
- Commercialization Policy and Framework
- Equity, Diversity, and Inclusion in Research
- Research Alerts
- Funding
- Ethics and Regulatory Compliance
- Research Integrity and Conflict of Interest
- Patenting, Licensing, and Commercialization
- Honours and Awards
- Ontario Agri-Food Innovation Alliance
- Other Considerations and Resources
- Forms, Policies, Guidelines, and Procedures
- Interactive Support Sessions for Researchers
- Research Administration Information Management System (RAIMS)